PlainRecalls
FDA Drug Moderate Class II Terminated

Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28

Reported: July 19, 2023 Initiated: July 5, 2023 #D-0913-2023

Product Description

Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28

Reason for Recall

Failed Moisture Limits: Water (moisture) content above the approved product specifications.

Details

Units Affected
180 bottles
Distribution
Product was distributed to 3 wholesalers/distributors who further distributed the product Nationwide in the USA.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28. Recalled by Teva Pharmaceuticals USA Inc. Units affected: 180 bottles.
Why was this product recalled?
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2023. Severity: Moderate. Recall number: D-0913-2023.